48 | Chapter 2 137. Hsu, L.-Y. et al. A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity 19, 105–17 (2003). 138. Chen, Z. et al. Transcription factors E2A, FOXO1 and FOXP1 regulate recombination activating gene expression in cancer cells. PLoS One 6, e20475 (2011). 139. Dekker, J. D. et al. Loss of the FOXP1 Transcription Factor Leads to Deregulation of B Lymphocyte Development and Function at Multiple Stages. ImmunoHorizons 3, 447– 462 (2019). 140. Amin, R. H. & Schlissel, M. S. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat. Immunol. 9, 613–22 (2008). 141. Schulz, D. et al. Gfi1b negatively regulates Rag expression directly and via the repression of FoxO1. J. Exp. Med. 209, 187–199 (2012). 142. Timblin, G. A. & Schlissel, M. S. Ebf1 and c-Myb repress rag transcription downstream of Stat5 during early B cell development. J. Immunol. 191, 4676–4687 (2013). 143. Miyazaki, K. & Miyazaki, M. The Interplay Between Chromatin Architecture and Lineage-Specific Transcription Factors and the Regulation of Rag Gene Expression. Front. Immunol. 12, 659761 (2021). 144. Lennartsson, J. & Rönnstrand, L. Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol. Rev. 92, 1619– 1649 (2012). 145. Dolence, J. J., Gwin, K. A., Shapiro, M. B. & Medina, K. L. Flt3 signaling regulates the proliferation, survival, and maintenance of multipotent hematopoietic progenitors that generate B cell precursors. Exp. Hematol. 42, 380-393.e3 (2014). 146. Hinman, R. M. et al. Foxo3-/- mice demonstrate reduced numbers of pre-B and recirculating B cells but normal splenic B cell sub-population distribution. Int. Immunol. 21, 831–842 (2009). 147. Dengler, H. S. et al. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat. Immunol. 9, 1388–98 (2008). 148. Burgering, B. M. T. A brief introduction to FOXOlogy. Oncogene 27, 2258–2262 (2008). 149. Chen, J., Limon, J. J., Blanc, C., Peng, S. L. & Fruman, D. A. Foxo1 regulates marginal zone B-cell development. Eur. J. Immunol. 40, 1890–1896 (2010). 150. Hu, X., Li, J., Fu, M., Zhao, X. & Wang, W. The JAK/STAT signaling pathway: from bench to clinic. Signal Transduct. Target. Ther. 6, 402 (2021). 151. Malin, S., McManus, S. & Busslinger, M. STAT5 in B cell development and leukemia. Curr. Opin. Immunol. 22, 168–176 (2010). 152. Zhang, L., Reynolds, T. L., Shan, X. & Desiderio, S. Coupling of V(D)J recombination to the cell cycle suppresses genomic instability and lymphoid tumorigenesis. Immunity 34, 163–74 (2011). 153. Quong, M. W. et al. Receptor editing and marginal zone B cell development are regulated by the helix-loop-helix protein, E2A. J. Exp. Med. 199, 1101–1112 (2004). 154. Novak, R., Jacob, E., Haimovich, J., Avni, O. & Melamed, D. The MAPK/ERK and PI3K pathways additively coordinate the transcription of recombination-activating genes in B lineage cells. J. Immunol. 185, 3239–3247 (2010). 155. Reth, M. et al. The B-cell antigen receptor complex. Immunol. Today 12, 196–201 (1991). 156. Heltemes-Harris, L. M. et al. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia. J. Exp. Med. 208, 1135–1149 (2011). 157. Malin, S. et al. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat. Immunol. 11, 171–179 (2010). 158. Herzog, S., Reth, M. & Jumaa, H. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat. Rev. Immunol. 9, 195–205 (2009). 159. Zhang, L., Reynolds, T. L., Shan, X. & Desiderio, S. Coupling of V(D)J recombination to the cell cycle suppresses genomic instability and lymphoid tumorigenesis. Immunity 34, 163–174 (2011).
RkJQdWJsaXNoZXIy MTk4NDMw